Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2025-01-07 00:00:00 ET · period of report 2025-01-06 · accession 0001415889-25-001014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-01-07 | 2025-01-06 | FENC | Raykov Rosty | Dir | S - Sale | $6.08 | -10.0K | 83.9K | -11% | -$60.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2025-01-06 | S | D | 2,431 | $6.08 | 91,432 | D | — | — | (F1) Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. |
| 2 | Common | Common shares | 2025-01-06 | S | D | 7,569 | $6.08 | 83,863 | D | — | — | (F2) Shares acquired through the exercise of an option contract with strike price of $2.36 on August 13, 2020. |